Biodistribution of tumor-targeted MXene-antibody conjugates
Open Access
- 25 August 2026
- journal article
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 14 (17) , 4614-4637
Abstract
An antibody-functionalized MXene-polydopamine nanoplatform enables intratumoral and intravenous in vivo tumor targeting with minimal off-target accumulation in clearance organs, supporting safe and effective cancer therapy.Keywords
Funding Information
- Horizon 2020 Framework Programme (101086184)
This publication has 59 references indexed in Scilit:
- Biocompatibility and immunomodulation of MXenes for targeted delivery of bioactive agents and drugsBioactive Materials, 2026
- Polydopamine‐Enabled Biomimetic Surface Engineering of Materials: New Insights and Promising ApplicationsAdvanced Materials Interfaces, 2023
- MXenes as theranostics: Diagnosis and therapy including in vitro and in vivo applicationsApplied Materials Today, 2023
- Recent Advances in Photothermal Therapy at Near‐Infrared‐II Based on 2D MXenesSmall, 2023
- In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatformsExploration, 2023
- Understanding the Photothermal and Photocatalytic Mechanism of Polydopamine Coated Gold NanorodsAdvanced Functional Materials, 2023
- Electrochemical and fluorescent dual-mode sensor of acetylcholinesterase activity and inhibition based on MnO2@PD-coated surfaceAnalytica Chimica Acta, 2023
- Theranostic 2D Tantalum Carbide (MXene)Advanced Materials, 2017
- Black Phosphorus Nanosheet‐Based Drug Delivery System for Synergistic Photodynamic/Photothermal/Chemotherapy of CancerAdvanced Materials, 2016
- Photothermal Poly(N‐isopropylacrylamide)/Fe3O4 Nanocomposite Hydrogel as a Movable Position Heating Source under Remote ControlSmall, 2014